Clinical Trial Update: Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan

View source ↗

Summary

A completed Japanese post-marketing surveillance study evaluated the adequacy of image interpretation criteria for Zevalin (ibritumomab tiuxetan) in non-Hodgkin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Zevalin (ibritumomab tiuxetan)

Snippet

Sponsor: Bayer | Conditions: Non-Hodgkin's Lymphoma (NHL) | Status: COMPLETED